How Modified-Release Dosage Forms Benefit Both The Patient And The Innovator

Source: AbbVie

By Yihong Qiu, Ph.D.


Whether your goal is to increase patient compliance, improve clinical outcomes, or to extend a product’s lifecycle, modified-release dosage forms present a solution to a myriad of issues. The challenge is to understand the influence of both drug property and delivery technology on drug design, and to give you enough time to select and introduce the ideal release form for both therapeutic and economic advantage.

Unlike immediate-release forms, which act quickly, modified-release forms are intended to act over a longer time period or delay action until they have reached a specific area – the stomach, small intestine, or colon, for example. There are different names for different modifications:

  • delayed release for specific sites or times
  • extended release for sustained or controlled drug exposure
  • programmed release such as pulsatile or biphasic

In the area of modified-release dosage forms, there is no “one-size-fits-all” delivery technology. Read more about the benefits of modified release and considerations for contracting MR manufacturing.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma